Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-CCL2 (Carlumab)-SMCC-DM1 is an antibody-drug conjugate (ADC) consisting of the human-derived anti-CCL2 (chemokine ligand 2) antibody Carlumab linked to the cytotoxic microtubule inhibitor DM1 through the linker SMCC. The ADC's toxic molecule and linker component are SMCC-DM1. This compound is applicable in cancer research, particularly for studying prostate cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Anti-CCL2 (Carlumab)-SMCC-DM1 is an antibody-drug conjugate (ADC) consisting of the human-derived anti-CCL2 (chemokine ligand 2) antibody Carlumab linked to the cytotoxic microtubule inhibitor DM1 through the linker SMCC. The ADC's toxic molecule and linker component are SMCC-DM1. This compound is applicable in cancer research, particularly for studying prostate cancer. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Target | CCL2 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.